News

CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide

NASHVILLE, TN / ACCESSWIRE / April 26, 2024 / The latest data from the US Census Bureau reflects alarming statistics…

2 years ago

Senzime Signs its First Group Purchasing Organization (GPO) Contract with Major US Hospital System as Sole Source Supplier

UPPSALA, SWEDEN / ACCESSWIRE / April 26, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) has secured a three-year GPO contract with one of…

2 years ago

Curiteva Announces David Schmidt as Chief Commercial Officer

HUNTSVILLE, AL / ACCESSWIRE / April 26, 2024 / Curiteva, a privately held manufacturing and technology company, announces the appointment…

2 years ago

Notice Of Annual General Meeting in PMD Device Solutions AB (PUBL)

STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The shareholders of PMD Device Solutions AB…

2 years ago

Biotricity’s Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2024 / Biotricity Inc. (NASDAQ:BTCY), a pioneering Technology-as-a-Service (TaaS) company dedicated to…

2 years ago

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell…

2 years ago

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready…

2 years ago

QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results

WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital…

2 years ago

Exagen Inc. Announces Changes to the Board of Directors

CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today…

2 years ago